Estimands for Early Phase Dose Optimization Trials in Oncology

Ayon Mukherjee, Jonathan L. Moscovici, Zheng Liu

Phase I dose escalation trials in oncology generally aim to find the maximum tolerated dose (MTD). However, with the advent of molecular targeted therapies and antibody drug conjug…